市北高新(600604.SH):子公司擬公開掛牌轉讓松銘地產28%股權
格隆匯9月22日丨市北高新(600604.SH)公佈,鑑於公司控股子公司市北祥騰的參股公司松銘地產開發建設的“雲間錦院”住宅項目已完成了各個環節的開發、建設與銷售等工作。為提高市北祥騰資產使用效率,及時回籠資金,市北祥騰擬在北京產權交易所以公開掛牌方式轉讓其所持有的松銘地產28%股權。
本次股權轉讓的首次掛牌價格預計將不低於人民幣702.4752萬元,最終轉讓價格取決於受讓方在北京產權交易所的實際成交價格。本次股權轉讓市北祥騰所持有的松銘地產28%股權與首創正恒所持有的松銘地產28%股權將整體捆綁掛牌轉讓。若本次交易順利完成,市北祥騰將不再持有松銘地產的股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.